Lucas Delmonico (L Delmonico)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

Current oncology (Toronto, Ont.)

Anais da Academia Brasileira de Ciencias

Disease markers

Exploration of targeted anti-tumor therapy

Universidade do Estado do Rio de Janeiro (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Universidade do Estado do Rio de Janeiro Mar 01 2015 - Feb 01 2019

Brazil

PHD :: General Pathology

Bioarray Therapeutics (United States) Aug 18 2017 - Jul 31 2018

United States

PHD

Universidade do Estado do Rio de Janeiro Dec 18 2012 - Nov 26 2014

Brazil

MSC :: General Pathology

Universidade Federal de Goiás Mar 01 2008 - Dec 15 2011

Brazil

BSC :: Unidade Jatobá

Publications

Lucas Delmonico, José Bines, Cristina Moreira do Nascimento, Priscila Valverde Fernandes, Isabel de Souza Barbosa, Gabriel Brito Ribeiro, Bruno Henrique Rala de Paula, Rafaele Tavares Silvestre, Maria Helena Faria Ornellas, Gilda Alves, Claudia Lage
Nuclear and Cytoplasmic hTERT, Tumor-Infiltrating Lymphocytes, and Telomere Elongation Leukocytes Are Independent Factors in the Response to Neoadjuvant Treatment in HER2-Enriched Breast Cancer. Current oncology (Toronto, Ont.) 30 (4) (2023)
Lucas Delmonico, José Bines, Cristina Moreira do Nascimento, Priscila Valverde Fernandes, Isabel de Souza Barbosa, Gabriel Brito Ribeiro, Bruno Henrique Rala de Paula, Rafaele Tavares Silvestre, Maria Helena Faria Ornellas, Gilda Alves, Claudia Lage
Nuclear and Cytoplasmic hTERT, Tumor-Infiltrating Lymphocytes, and Telomere Elongation Leukocytes Are Independent Factors in the Response to Neoadjuvant Treatment in HER2-Enriched Breast Cancer. Current oncology (Toronto, Ont.) 30 (4) (2023)
Lucas Delmonico, José Bines, Cristina Moreira do Nascimento, Priscila Valverde Fernandes, Isabel de Souza Barbosa, Gabriel Brito Ribeiro, Bruno Henrique Rala de Paula, Rafaele Tavares Silvestre, Maria Helena Faria Ornellas, Gilda Alves, Claudia Lage
Nuclear and Cytoplasmic hTERT, Tumor-Infiltrating Lymphocytes, and Telomere Elongation Leukocytes Are Independent Factors in the Response to Neoadjuvant Treatment in HER2-Enriched Breast Cancer. Current oncology (Toronto, Ont.) 30 (4) (2023)
Mariana Chantre, Gilda Alves, Lucas Delmonico
Clinical applications of liquid biopsy in HPV-negative and HPV-positive head and neck squamous cell carcinoma: advances and challenges. Exploration of targeted anti-tumor therapy 3 (4) (2022)
Lucas Delmonico, John C Obenauer, T P Stockfisch, Marcia V Fournier
Housekeeping genes involved in non-malignant breast phenotypes are widely expressed in multiple cancers and provide novel biomarkers of tumor classification. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 54 (7) (2021)
Gilda Alves, Mariana Chantre, Lucas Delmonico
The contribution of the 20th century discoveries on the circulating DNA as biomarkers for cancer screening. Anais da Academia Brasileira de Ciencias 92 (4) (2020)
Lucas Delmonico, Said Attiya, Joan W Chen, John C Obenauer, Edward C Goodwin, Marcia V Fournier
Expression Concordance of 325 Novel RNA Biomarkers between Data Generated by NanoString nCounter and Affymetrix GeneChip. Disease markers 2019 (2019)

Lucas Delmonico.css-eqlu8i{font-size:small;padding-left:4px;} (L Delmonico)

Publication Activity (10 Years)

Top Topics

Top Venues

Lucas Delmonico (L Delmonico)